Hikma Pharmaceuticals PLC.

Company Overview

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and supplies generic and branded medicines. It operates through three core business segments: injectables, branded, and generics. The injectables business supplies hospitals with a wide range of sterile medicines used in acute and critical care settings. The generics segment provides oral and topical medicines, mainly in the U.S., where it serves retail pharmacies and healthcare providers. The branded business is concentrated in the Middle East and North Africa and offers prescription medicines for both chronic and acute conditions.

Hikma Pharmaceuticals PLC has an agreement with Takeda Pharmaceutical that allows it to manufacture and market azilsartan, including the combination with chlorthalidone, in the Middle East and North Africa region.

Financial Highlights (FY 2025)

Company's Business Segments

• Injectables : The company supplies hospitals across its markets with generic and specialty injectable products, supported by our US, Europe, and MENA manufacturing facilities.
• Hikma Rx : The company supply oral, respiratory and other generic and specialty products to the North American retail market, leveraging our state-of-the-art manufacturing facility in Columbus, Ohio.
• Branded : The company supplies oral, respiratory, and other generic and specialty products to the North American retail market, leveraging its advanced manufacturing facility in Columbus, Ohio.